Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata

NCT03551821 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata
Alopecia Totalis
Alopecia Universalis

Interventions

DRUG: ATI-50002

Sponsor

Aclaris Therapeutics, Inc.